Marjon Kerkhof

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi request reprint Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Histopathology 50:920-7. 2007
  2. ncbi request reprint Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Endoscopy 39:772-8. 2007
  3. ncbi request reprint Biomarkers for risk stratification of neoplastic progression in Barrett esophagus
    Marjon Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cell Oncol 29:507-17. 2007
  4. doi request reprint Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study
    Marjolein Sikkema
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Gastroenterol 104:2673-80. 2009
  5. ncbi request reprint Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus
    Marjon Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cancer Biomark 4:1-10. 2008
  6. ncbi request reprint Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low
    Michelle E Kruijshaar
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, The Netherlands
    Gastrointest Endosc 65:26-30. 2007
  7. ncbi request reprint Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus
    Pieter J F de Jonge
    Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Am J Gastroenterol 101:1421-9. 2006
  8. ncbi request reprint Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 24:1613-21. 2006
  9. ncbi request reprint Respiratory infections in infants: interaction of parental allergy, child care, and siblings-- The PIAMA study
    L P Koopman
    Department of Pediatrics, Sophia Children s Hospital, Erasmus University, Rotterdam, The Netherlands
    Pediatrics 108:943-8. 2001

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Histopathology 50:920-7. 2007
    ..To determine interobserver variation in grading of dysplasia in Barrett's oesophagus (BO) between non-expert general pathologists and expert gastrointestinal pathologists on the one hand and between expert pathologists on the other hand...
  2. ncbi request reprint Predicting presence of intestinal metaplasia and dysplasia in columnar-lined esophagus: a multivariate analysis
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Endoscopy 39:772-8. 2007
    ..In patients with presumed Barrett esophagus we evaluated clinical risk factors that could predict the presence of intestinal metaplasia and dysplasia in biopsies of columnar-lined esophagus (CLE), independently of histological results...
  3. ncbi request reprint Biomarkers for risk stratification of neoplastic progression in Barrett esophagus
    Marjon Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cell Oncol 29:507-17. 2007
    ..e. proliferation/cell cycle proteins, tumor suppressor genes, adhesion molecules, DNA ploidy status and inflammation associated markers, that can be used for risk stratification in BE, and discuss their respective clinical application...
  4. doi request reprint Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study
    Marjolein Sikkema
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Am J Gastroenterol 104:2673-80. 2009
    ..The aim of this study was to determine the predictive value of p53, Ki67, and aneuploidy as markers of neoplastic progression in BE...
  5. ncbi request reprint Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus
    Marjon Kerkhof
    Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Cancer Biomark 4:1-10. 2008
    ..Accumulation of p53 was seen several years before development of HGD/EAC, and may therefore be an early marker in BE at a stage when dysplasia is not yet detected. A prospective follow-up study is needed to confirm these findings...
  6. ncbi request reprint Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low
    Michelle E Kruijshaar
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, The Netherlands
    Gastrointest Endosc 65:26-30. 2007
    ..The risk of developing esophageal adenocarcinoma (EAC) for patients with Barrett's esophagus (BE) is approximately 0.5% per year...
  7. ncbi request reprint Risk factors for the development of esophageal adenocarcinoma in Barrett's esophagus
    Pieter J F de Jonge
    Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Am J Gastroenterol 101:1421-9. 2006
    ..To identify risk factors for esophageal adenocarcinoma (EAC) in patients with Barrett's esophagus (BE)...
  8. ncbi request reprint Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?
    M Kerkhof
    Department of Gastroenterology and Hepatology, Erasus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 24:1613-21. 2006
    ..As intestinal metaplasia and cardiac-type mucosa are endoscopically indiscernible, it is difficult to take targeted samples from columnar-lined oesophagus with consequently a risk of having undetected intestinal metaplasia...
  9. ncbi request reprint Respiratory infections in infants: interaction of parental allergy, child care, and siblings-- The PIAMA study
    L P Koopman
    Department of Pediatrics, Sophia Children s Hospital, Erasmus University, Rotterdam, The Netherlands
    Pediatrics 108:943-8. 2001
    ..To investigate the association between contacts with other children and the development of respiratory infections in the first year of life in children with or without genetic predisposition for allergy...